Xiaolin Zhang

784 citations
52 papers · 571 indexed · h-index 17
Topics
Atherosclerosis and Cardiovascular Diseases (6 papers)Liver Disease Diagnosis and Treatment (5 papers)Chemokine receptors and signaling (4 papers)

In The Last Decade

Xiaolin Zhang

42 papers receiving 565 citations

Peers

Xiaolin Zhang
Comparison fields: 5 of 97
  • Molecular Biology 209
  • Immunology 134
  • Epidemiology 106
  • Cancer Research 104
  • Oncology 75
Replace Lingling Shu with:
Lingling Shu China
Marta F. Bustamante Spain
Weihua Gong China
Makiko Kumagai‐Braesch Sweden
Xiao‐Feng Lei Japan
Howard E. Boudreau United States
Hongli Song China
Nicholas A. Young United States
Xiaolin Zhang relative to Lingling Shu China Lingling Shu's profile →
Citations per field
00.5×4.5×
Lingling Shu · 1×
Citations per year

Countries citing papers authored by Xiaolin Zhang

Since Specialization
Citations

This map shows the geographic impact of Xiaolin Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaolin Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaolin Zhang more than expected).

Fields of papers citing papers by Xiaolin Zhang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaolin Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaolin Zhang. The network helps show where Xiaolin Zhang may publish in the future.

Co-authorship network of co-authors of Xiaolin Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaolin Zhang. A scholar is included among the top collaborators of Xiaolin Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaolin Zhang. Xiaolin Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 3
3 4
4 1
5 0
6 0
7 10
8 8
9 19
10 23
11 23
12 6
13
Selection and optimization of total RNA extraction methods from Magnolia sieboldii different tissues
1
14 26
15 10
16 31
17 13
18 27
19 16
20 12

About Xiaolin Zhang

Xiaolin Zhang is a scholar working on Biological Psychiatry, Hepatology and Immunology and Allergy, having authored 52 papers that have together received 571 indexed citations. Recurring topics across this work include Atherosclerosis and Cardiovascular Diseases (6 papers), Liver Disease Diagnosis and Treatment (5 papers) and Chemokine receptors and signaling (4 papers). The work is most often cited by research in Cancer Research (104 citations), Hepatology (51 citations) and Immunology (134 citations). Xiaolin Zhang has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Yaling Han, Chenghui Yan, Xiaoxiang Tian, Jian Kang, Jie Tao, Tengfei Liu, Dianwu Liu, Liang Guo, Jie Deng and Xing Lin. Their work appears in journals such as Blood, Small and Arteriosclerosis Thrombosis and Vascular Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026